Bausch Health Companies Inc. (BHC) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $8.21 (-7.86%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 7, 2026 | Les Sulewski | Truist Financial | $8.00 | -2.6% |
| Dec 8, 2025 | Glen Santangelo | Barclays | $8.00 | -2.6% |
| Oct 23, 2024 | Douglas Miehm | RBC Capital | $10.00 | +21.8% |
| Jul 25, 2024 | Les Sulewski | Truist Financial | $7.00 | -14.7% |
| Jul 10, 2024 | Michael Freeman | Raymond James | $8.00 | -2.6% |
| Apr 29, 2024 | David Amsellem | Piper Sandler | $9.00 | +9.6% |
| Apr 23, 2024 | Doug Miehm | RBC Capital | $11.00 | +34.0% |
| Apr 11, 2024 | Glen Santangelo | Jefferies | $16.00 | +94.9% |
| Apr 5, 2024 | Doug Miehm | RBC Capital | $12.00 | +46.2% |
Top Analysts Covering BHC
BHC vs Sector & Market
| Metric | BHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.25 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +3.5% | +153002.0% | +21.5% |
| P/E Ratio | 8.87 | 3.46 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.84B | $2.87B | $2.90B | 3 |
| 2027-03-31 | $2.41B | $2.43B | $2.45B | 3 |
| 2027-06-30 | $2.62B | $2.64B | $2.66B | 2 |
| 2027-09-30 | $2.71B | $2.74B | $2.76B | 2 |
| 2027-12-31 | $2.84B | $2.87B | $2.89B | 3 |
| 2028-12-31 | $9.81B | $9.83B | $9.86B | 3 |
| 2029-12-31 | $9.70B | $9.74B | $9.79B | 2 |
| 2030-12-31 | $9.72B | $9.77B | $9.81B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.35 | $1.37 | $1.38 | 2 |
| 2027-03-31 | $0.65 | $0.65 | $0.66 | 2 |
| 2027-06-30 | $0.92 | $0.93 | $0.94 | 1 |
| 2027-09-30 | $1.14 | $1.15 | $1.16 | 1 |
| 2027-12-31 | $1.22 | $1.23 | $1.24 | 2 |
| 2028-12-31 | $3.08 | $3.09 | $3.11 | 2 |
| 2029-12-31 | $3.32 | $3.34 | $3.36 | 1 |
| 2030-12-31 | $3.59 | $3.61 | $3.63 | 1 |
Frequently Asked Questions
What is the analyst consensus for BHC?
The consensus among 2 analysts covering Bausch Health Companies Inc. (BHC) is Hold with an average price target of $9.00.
What is the highest price target for BHC?
The highest price target for BHC is $16.00, set by Glen Santangelo at Jefferies on 2024-04-11.
What is the lowest price target for BHC?
The lowest price target for BHC is $7.00, set by Les Sulewski at Truist Financial on 2024-07-25.
How many analysts cover BHC?
2 analysts have issued ratings for Bausch Health Companies Inc. in the past 12 months.
Is BHC a buy or sell right now?
Based on 2 analyst ratings, BHC has a consensus rating of Hold (3.00/5) with a +3.5% upside to the consensus target of $9.00.
What are the earnings estimates for BHC?
Analysts estimate BHC will report EPS of $1.37 for the period ending 2026-12-31, with revenue estimated at $2.87B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.